Search Results 1131-1140 of 16737 for intermittent fasting optimization

  1. A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. ... Diet in Renal Disease [MDRD] ...

  2. Mayo Clinic

    Bob Thompson Patient Story. Sections. Products and services. The Mayo Clinic Diet: What is your weight-loss goal? 5-10. Something went wrong. An error occurred ...

  3. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  4. Breast Clinic - Clinical trials

    Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment. Scottsdale/Phoenix, Ariz. The purpose of this study is to identify subtype ...

  5. SMOFLipid in Intralipid Intolerant - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  6. Research using latent class analysis reveals distinct patient clusters based on clinical, dietary, lifestyle and psychosocial factors associated with IBS

    Study results. Using 26 variables to separate the IBS cohort from the control group, the optimal clustering model helped the researchers identify seven latent ...

  7. A Study Of ART24 In Subjects Recently Cured Of A Clostridioides Difficile Infection (CDI) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3) ... diet, active gastroparesis, toxic megacolon, pseudomembranous colitis, colostomy ...

  8. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3) ... Subjects that require intermittent use of bronchodilators or local steroid ...

  9. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  10. A Study To Evaluate The Effectiveness, Safety And Tolerability Of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...